Clinical trial
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed…
NCT00006388 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006388 |
|---|---|
| Title | Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme |
| Official title | A Phase II Trial of High Dose Tamoxifen For The Treatment of Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM) |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | tamoxifen citrate, radiation therapy |
| Enrollment | 77 |
| Start date | Dec 1, 2000 |
| Primary completion | Oct 1, 2003 |
| First posted | Feb 12, 2004 |
| Last update posted | Oct 22, 2020 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: